Declining prevalence of cytological squamous intraepithelial lesions of the cervix among women living with well‐controlled HIV – Most women living with HIV do not need annual PAP smear screening
- 19 September 2017
- journal article
- research article
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 96 (11) , 1330-1337
Abstract
Introduction: Cervical screening by means of annual Papanicolaou (PAP) smears has been recommended for all women living with HIV. We analysed the results of our annual PAP smear screening program to identify low‐risk subgroups for less rigorous screening.Material and methods: The study comprised 369 women followed at the Helsinki University Hospital 2002–2013, with a total of 2033 PAP smear results. We analyzed the temporal changes in PAP smear findings. Logistic regression analysis for binominal dependent variables was used for assessing risk factors for ever having cytological squamous intraepithelial lesions (hereafter referred as SIL) using generalized estimating equations taking into account multiple observations of each patient.Results: Most women had well‐controlled HIV, especially towards the end of the study. PAP smear results improved substantially. At the time of each individual's last PAP smear, 90.0% of the findings displayed normal results. Conversely, the rate of SIL decreased from 16.8% to 4.6% from 2002 to 2013. In multivariate analysis the risk of SIL was significantly lower in women with consecutive normal PAP smear findings during the first two years of follow up [odds ratio (OR) 0.21, 95% confidence interval (CI) 0.10–0.45, p < 0.001] and with CD4 counts >500 cells/μL (OR 0.11, 95% CI 0.05–0.26, p < 0.001).Conclusions: Widespread use of combination antiretroviral therapy (cART) and systematic cervical screening has reduced the rate of abnormal PAP smears. It seems feasible to identify low‐risk women by combining HIV‐related information and PAP smear results. Screening low‐risk women living with HIV at three‐year intervals similar to HIV‐negative women appears justified.Keywords
Funding Information
- Bristol-Myers Squibb (AI424‐1002)
- Suomen Lääketieteen Säätiö
This publication has 19 references indexed in Scilit:
- Incidence and progression of cervical lesions in women with HIV: a systematic global reviewInternational Journal of STD & AIDS, 2013
- 2012 Updated Consensus Guidelines for the Management of Abnormal Cervical Cancer Screening Tests and Cancer PrecursorsObstetrics & Gynecology, 2013
- Risk of Cervical Precancer and Cancer Among HIV-Infected Women With Normal Cervical Cytology and No Evidence of Oncogenic HPV InfectionJAMA, 2012
- Screening for Cervical Cancer: U.S. Preventive Services Task Force Recommendation StatementAnnals of Internal Medicine, 2012
- Influence of Adherent and Effective Antiretroviral Therapy Use on Human Papillomavirus Infection and Squamous Intraepithelial Lesions in Human Immunodeficiency Virus–Positive WomenThe Journal of Infectious Diseases, 2010
- HIV, human papillomavirus, and cervical neoplasia and cancer in the era of highly active antiretroviral therapyEuropean Journal Of Cancer Prevention, 2008
- Prevalence of Human Papillomavirus Genotypes and Related Abnormalities of Cervical Cytological Results among HIV‐1–Infected Women in Rochester, New YorkThe Journal of Infectious Diseases, 2006
- Cancer Risk in the Swiss HIV Cohort Study: Associations With Immunodeficiency, Smoking, and Highly Active Antiretroviral TherapyJNCI: Journal of the National Cancer Institute, 2005
- Highly Active Antiretroviral Therapy and Incidence of Cancer in Human Immunodeficiency Virus-Infected AdultsJNCI: Journal of the National Cancer Institute, 2000
- 1993 Revised Classification System for HIV Infection and Expanded Surveillance Case Definition for AIDS Among Adolescents and AdultsJAMA, 1993